Agios Pharmaceuticals, Inc. (AGIO)
28.33
+0.19
(+0.68%)
USD |
NASDAQ |
May 26, 16:00
28.32
-0.01
(-0.04%)
Pre-Market: 20:00
Agios Pharmaceuticals Total Liabilities (Quarterly) : 75.88M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Apellis Pharmaceuticals, Inc. (DELISTED) | 667.61M |
| Amgen, Inc. | 83.31B |
| MannKind Corp. | 803.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.185B |
| Shareholders Equity (Quarterly) | 1.109B |
| Debt to Equity Ratio | 0.0322 |
| Current Ratio | 14.19 |
| Net Debt Paydown Yield | 0.21% |